FDA grants emergency use authorization of Pfizer's Bivalent Covid booster for kids
The following is an excerpt from Medscape. Pfizer Inc said on Tuesday that the US Food and Drug Administration had expanded the emergency use authorization (EUA) of the company and its partner BioNTech SE’s bivalent Covid-19 vaccine as a single booster dose in certain children. The amended authorization is for children six months through four years […]
Continue reading FDA grants emergency use authorization of Pfizer's Bivalent Covid booster for kids on sharylattkisson.com.
